Document is current

Any future updates will be listed below

High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer

Crossref DOI link: https://doi.org/10.1007/s00066-016-0979-7

Published Online: 2016-05-31

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark